astemizole has been researched along with Experimental Neoplasms in 2 studies
Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
Excerpt | Relevance | Reference |
---|---|---|
"Astemizole was administered with the food to mice for 18 and to rats for 24 consecutive months." | 1.29 | Carcinogenicity studies of astemizole in mice and rats. ( Benze, J; Bowden, C; De Coster, R; Gypen, L; Lampo, A; Van Cauteren, H; Vandenberghe, J, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benze, J | 1 |
Gypen, L | 1 |
Vandenberghe, J | 1 |
Lampo, A | 1 |
De Coster, R | 1 |
Bowden, C | 1 |
Van Cauteren, H | 1 |
2 other studies available for astemizole and Experimental Neoplasms
Article | Year |
---|---|
Carcinogenicity studies of astemizole in mice and rats.
Topics: Aging; Animals; Astemizole; Carcinogenicity Tests; Dose-Response Relationship, Drug; Female; Histami | 1995 |
Ambivalent antihistamines.
Topics: Animals; Astemizole; Carcinogens; Histamine H1 Antagonists; Hydroxyzine; Loratadine; Mice; Neoplasms | 1994 |